Lisi, Lucia
 Distribuzione geografica
Continente #
EU - Europa 3.226
NA - Nord America 2.750
AS - Asia 612
SA - Sud America 6
AF - Africa 3
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.601
Nazione #
US - Stati Uniti d'America 2.724
PL - Polonia 1.233
DE - Germania 697
IT - Italia 421
SE - Svezia 308
CN - Cina 254
UA - Ucraina 172
SG - Singapore 164
GB - Regno Unito 96
IE - Irlanda 88
FR - Francia 81
IN - India 68
ID - Indonesia 60
FI - Finlandia 46
RU - Federazione Russa 32
VN - Vietnam 20
CA - Canada 18
BE - Belgio 17
TR - Turchia 17
ES - Italia 12
MX - Messico 8
NL - Olanda 8
JP - Giappone 7
HK - Hong Kong 6
CH - Svizzera 4
CL - Cile 4
IR - Iran 4
CZ - Repubblica Ceca 3
AU - Australia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
LT - Lituania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
GR - Grecia 1
KR - Corea 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 6.601
Città #
Warsaw 1.218
Chandler 441
Ashburn 245
Fairfield 245
Jacksonville 135
Singapore 134
Houston 133
Wilmington 131
Woodbridge 129
San Mateo 107
Cattolica 98
Seattle 92
Dublin 88
Verona 84
Ann Arbor 82
Cambridge 82
Nanjing 63
Jakarta 59
Dearborn 49
Bremen 46
New York 46
Munich 44
Rome 43
Milan 42
Redwood City 40
Nürnberg 36
Lawrence 33
Nanchang 31
Boston 30
Beijing 24
Chicago 24
Moscow 24
Princeton 21
Lancaster 20
Brussels 17
Dong Ket 17
Marseille 15
Mountain View 15
Kraków 14
Pune 14
Redmond 14
Hangzhou 13
San Diego 13
University Park 13
Phoenix 12
Izmir 11
London 11
Los Angeles 11
Norwalk 11
Shanghai 11
Shenyang 11
Boardman 10
Changsha 10
Fremont 10
Jiaxing 10
Leawood 10
Montesilvano Marina 10
Zhengzhou 10
Busto Arsizio 9
Toronto 9
Hebei 8
Helsinki 7
Paris 7
Andover 6
Falls Church 6
Guangzhou 6
Kunming 6
Monmouth Junction 6
Nanning 6
Corchiano 5
Gurgaon 5
Philadelphia 5
Chiswick 4
Fondi 4
Frankfurt am Main 4
Hefei 4
Hong Kong 4
Jinan 4
Senigallia 4
Trento 4
Augusta 3
Detroit 3
Florence 3
Gustavo Adolfo Madero 3
Halifax 3
Madrid 3
Manchester 3
Orwell 3
Santa Clara 3
Tianjin 3
Viterbo 3
Zurich 3
Addison 2
Akhisar 2
Anzio 2
Bogen 2
Brooklyn 2
Broomfield 2
Budapest 2
Camerino 2
Totale 4.587
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 357
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 351
mTOR kinase: a possible pharmacological target in the management of chronic pain 350
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 320
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 306
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 305
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 304
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 278
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis 160
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis 141
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 138
Antiretrovirals inhibit arginase in human microglia 129
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 126
Variability of raltegravir plasma levels in the clinical setting 125
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 119
Pro-inflammatory activation of a new immortalized human microglia cell line 112
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 109
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 108
Antiretrovirals inhibit arginase in human microglia 103
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 101
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 100
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 100
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 97
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 94
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 94
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 92
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 92
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 88
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 86
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 84
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 82
Exploiting microglial functions for the treatment of glioblastoma 82
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 79
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 78
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 78
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 77
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 76
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 76
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 75
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 72
Exploiting Microglial Functions for the Treatment of Glioblastoma 70
Interactions between Integrase Inhibitors and human Arginase 1 69
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 68
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 68
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 66
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 66
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 64
DNA inhibitors for the treatment of brain tumors 62
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 58
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids 58
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 55
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples 53
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 53
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 44
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 37
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 30
The effects of painless nerve growth factor on human microglia polarization 29
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19 11
The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review 8
Totale 6.713
Categoria #
all - tutte 23.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020740 0 0 0 0 66 90 105 51 142 59 158 69
2020/2021907 58 100 25 74 115 64 147 20 105 65 97 37
2021/2022755 74 56 13 29 66 30 11 97 30 60 170 119
2022/20231.127 128 163 107 188 76 137 25 95 137 20 27 24
2023/2024607 35 146 27 53 27 68 65 33 9 13 52 79
2024/2025292 23 34 102 53 80 0 0 0 0 0 0 0
Totale 6.713